Journal article
Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis
Abstract
OBJECTIVE: To compare the efficacy of adalimumab and infliximab for the treatment of moderate to severe ulcerative colitis using indirect treatment comparison meta-analysis.
METHODS: A systematic review and Bayesian indirect treatment comparison meta-analyses were performed for seven patient-important clinical outcomes at 8 weeks and 52 weeks. Odds ratio (OR) estimates and associated 95% credible intervals (CrIs) were produced.
Authors
Thorlund K; Druyts E; Mills EJ; Fedorak RN; Marshall JK
Journal
Journal of Crohn's and Colitis, Vol. 8, No. 7, pp. 571–581
Publisher
Oxford University Press (OUP)
Publication Date
July 1, 2014
DOI
10.1016/j.crohns.2014.01.010
ISSN
1197-4982